🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

148,46 USD

Máx. histórico

156,92

14 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-5,39%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,24%

Cierre anterior

150,33

Rango de hoy

146,28 – 149,59

Volumen hoy

10.884.998

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
118,77 (puede no estar actualizado)
Dividend yield
2,26% (puede no estar actualizado)
Precio objetivo analistas
150,42 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 3 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,26%
Fecha de pago Importe por participación
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
14/12/2022 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
25/09/1987 10,59 10,71 10,57 10,60 -0,06% 1,31% 8.549.165
24/09/1987 10,83 10,85 10,60 10,60 -2,32% 2,33% 7.430.530
23/09/1987 10,81 10,89 10,80 10,85 +0,43% 0,86% 14.015.952
22/09/1987 10,56 10,81 10,38 10,81 +2,71% 4,08% 14.781.830
21/09/1987 10,72 10,76 10,46 10,52 -1,73% 2,84% 18.305.626
18/09/1987 10,75 10,83 10,70 10,71 +0,19% 1,17% 19.618.560
17/09/1987 10,97 10,99 10,60 10,69 -2,24% 3,50% 16.902.144
16/09/1987 11,11 11,19 10,89 10,93 -2,25% 2,62% 11.844.706
15/09/1987 11,25 11,29 11,17 11,19 -0,47% 1,06% 9.230.155
14/09/1987 11,30 11,32 11,21 11,24 +0,00% 0,94% 7.511.645
11/09/1987 11,27 11,34 11,17 11,24 -0,18% 1,59% 8.662.349
10/09/1987 11,36 11,36 11,09 11,26 -0,29% 2,39% 13.848.062
09/09/1987 11,32 11,38 11,24 11,29 +0,47% 1,29% 15.211.930
08/09/1987 11,19 11,24 10,97 11,24 -0,59% 2,37% 20.184.480
04/09/1987 11,50 11,52 11,26 11,30 -1,95% 2,19% 13.006.728
03/09/1987 11,23 11,82 11,21 11,53 +3,69% 5,43% 18.618.768
02/09/1987 11,11 11,15 10,97 11,12 +2,13% 1,55% 23.014.080
01/09/1987 11,03 11,15 10,87 10,89 +0,49% 2,52% 16.553.160
31/08/1987 10,60 10,84 10,60 10,83 +1,30% 2,25% 9.067.925
28/08/1987 10,83 10,87 10,68 10,70 -2,00% 1,71% 6.298.690
27/08/1987 10,93 11,00 10,89 10,91 -0,78% 0,97% 8.362.411
26/08/1987 11,07 11,08 10,99 11,00 -0,18% 0,84% 7.570.123
25/08/1987 10,95 11,08 10,95 11,02 +1,16% 1,21% 9.369.749
24/08/1987 10,97 11,00 10,87 10,89 -0,72% 1,21% 10.016.784
21/08/1987 11,01 11,04 10,92 10,97 -0,30% 1,08% 15.034.608
20/08/1987 11,00 11,07 10,93 11,01 +0,91% 1,21% 11.663.611
19/08/1987 10,73 10,91 10,73 10,91 +0,86% 1,61% 10.763.798
18/08/1987 10,95 10,96 10,73 10,81 -1,81% 2,06% 15.670.325
17/08/1987 10,85 11,01 10,83 11,01 +1,65% 1,71% 18.026.438
14/08/1987 10,71 10,89 10,71 10,83 -0,06% 1,67% 12.601.152